229 related articles for article (PubMed ID: 29760142)
1.
Tan J; Patil PC; Luzzio FA; Demuth DR
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760142
[TBL] [Abstract][Full Text] [Related]
2. Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.
Mahmoud MY; Steinbach-Rankins JM; Demuth DR
J Control Release; 2019 Mar; 297():3-13. PubMed ID: 30690103
[TBL] [Abstract][Full Text] [Related]
3. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
Rocco CJ; Bakaletz LO; Goodman SD
J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850
[TBL] [Abstract][Full Text] [Related]
4. Identification of Small-Molecule Inhibitors Targeting Porphyromonas gingivalis Interspecies Adherence and Determination of Their
Roky M; Tan J; Sztukowska MN; Trent JO; Demuth DR
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816725
[No Abstract] [Full Text] [Related]
5. 1,2,3-Triazole-based inhibitors of Porphyromonas gingivalis adherence to oral streptococci and biofilm formation.
Patil PC; Tan J; Demuth DR; Luzzio FA
Bioorg Med Chem; 2016 Nov; 24(21):5410-5417. PubMed ID: 27647373
[TBL] [Abstract][Full Text] [Related]
6. Selective substitution of amino acids limits proteolytic cleavage and improves the bioactivity of an anti-biofilm peptide that targets the periodontal pathogen, Porphyromonas gingivalis.
Daep CA; Novak EA; Lamont RJ; Demuth DR
Peptides; 2010 Dec; 31(12):2173-8. PubMed ID: 20800634
[TBL] [Abstract][Full Text] [Related]
7. Peptide-modified nanoparticles inhibit formation of
Kalia P; Jain A; Radha Krishnan R; Demuth DR; Steinbach-Rankins JM
Int J Nanomedicine; 2017; 12():4553-4562. PubMed ID: 28790818
[TBL] [Abstract][Full Text] [Related]
8. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
Mahmoud MY; Demuth DR; Steinbach-Rankins JM
J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Porphyromonas gingivalis with oral streptococci requires a motif that resembles the eukaryotic nuclear receptor box protein-protein interaction domain.
Daep CA; Lamont RJ; Demuth DR
Infect Immun; 2008 Jul; 76(7):3273-80. PubMed ID: 18474648
[TBL] [Abstract][Full Text] [Related]
10. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii.
Daep CA; Novak EA; Lamont RJ; Demuth DR
Infect Immun; 2011 Jan; 79(1):67-74. PubMed ID: 21041492
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation.
Daep CA; James DM; Lamont RJ; Demuth DR
Infect Immun; 2006 Oct; 74(10):5756-62. PubMed ID: 16988253
[TBL] [Abstract][Full Text] [Related]
12. Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease.
Kugaji MS; Kumbar VM; Peram MR; Patil S; Bhat KG; Diwan PV
APMIS; 2019 Apr; 127(4):187-195. PubMed ID: 30861212
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways underlying inhibitory effect of antimicrobial peptide Nal-P-113 on bacteria biofilms formation of Porphyromonas gingivalis W83 by DNA microarray.
Wang HY; Lin L; Tan LS; Yu HY; Cheng JW; Pan YP
BMC Microbiol; 2017 Feb; 17(1):37. PubMed ID: 28212615
[TBL] [Abstract][Full Text] [Related]
14. Role of gallium and silver from phosphate-based glasses on in vitro dual species oral biofilm models of Porphyromonas gingivalis and Streptococcus gordonii.
Valappil SP; Coombes M; Wright L; Owens GJ; Lynch RJ; Hope CK; Higham SM
Acta Biomater; 2012 May; 8(5):1957-65. PubMed ID: 22314314
[TBL] [Abstract][Full Text] [Related]
15. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation.
Shahzad M; Millhouse E; Culshaw S; Edwards CA; Ramage G; Combet E
Food Funct; 2015 Mar; 6(3):719-29. PubMed ID: 25585200
[TBL] [Abstract][Full Text] [Related]
16. Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.
Ho MH; Lamont RJ; Chazin WJ; Chen H; Young DF; Kumar P; Xie H
Mol Oral Microbiol; 2018 Dec; 33(6):430-439. PubMed ID: 30298683
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activities of natural lichen compounds against Streptococcus gordonii and Porphyromonas gingivalis.
Sweidan A; Chollet-Krugler M; Sauvager A; van de Weghe P; Chokr A; Bonnaure-Mallet M; Tomasi S; Bousarghin L
Fitoterapia; 2017 Sep; 121():164-169. PubMed ID: 28736072
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial and antibiofilm activities of eugenol from essential oil of Syzygium aromaticum (L.) Merr. & L. M. Perry (clove) leaf against periodontal pathogen Porphyromonas gingivalis.
Zhang Y; Wang Y; Zhu X; Cao P; Wei S; Lu Y
Microb Pathog; 2017 Dec; 113():396-402. PubMed ID: 29101062
[TBL] [Abstract][Full Text] [Related]
19. A novel peptidic inhibitor derived from Streptococcus cristatus ArcA attenuates virulence potential of Porphyromonas gingivalis.
Ho MH; Lamont RJ; Xie H
Sci Rep; 2017 Nov; 7(1):16217. PubMed ID: 29176569
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus cristatus ArcA interferes with Porphyromonas gingivalis pathogenicity in mice.
Xie H; Hong J; Sharma A; Wang BY
J Periodontal Res; 2012 Oct; 47(5):578-83. PubMed ID: 22448761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
